FierceBiotechOriginal article
{"a":[{"_":"BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challenger","$":{"href":"/biotech/blossomhill-eyes-112m-ipo-harvest-bankroll-potential-tagrisso-challenger","hreflang":"en"}}]}
IPO/OfferingTagrissoPositive
AI Analysis
Summary
BlossomHill Therapeutics plans to raise $111.7 million through an IPO to fund clinical development of a potential competitor to Tagrisso.
Importance:6/10
Sentiment:
0.60
IPOcapital_raiseclinical_developmentoncology
Related Companies
Read the original article
Published by FierceBiotech on August 3, 2026 9:24 AM